C21 · Pharmaceuticals · China
Beneficiaries of negotiated reimbursement drugs
China: 830 million person-visits in as of 31 Oct 2024.
- 830 million person-visits Latest · China · as of 31 Oct 2024
- Irregular Release cadence
- 2 Records · 1 region · 2018–2024
Verified 27 Sep 2026 · 2 publishers
Over time
China over time. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.
Beneficiaries of negotiated reimbursement drugs
China, January 2018 – October 2024 to as of 31 Oct 2024
View the underlying data
| Period | Type | Value |
|---|---|---|
| January 2018 – October 2024 | Actual | 830 million person-visits |
| as of 31 Oct 2024 | Actual | 830 million person-visits |
Every record
2 records · 1 region · 2018–2024. Each period links to its record: the value, its source evidence and original document.
| Period | Value | Source | Type |
|---|---|---|---|
| China 2 records | |||
| as of 31 Oct 2024 | 830 million person-visits | NHSA · 28 Nov 2024 | |
| January 2018 – October 2024 | 830 million | State Council · 31 Oct 2024 | |
Download this data
Every file carries its provenance: the CSV has a source column per row, and the chart images print the publisher, the licence and this page's address under the drawing. Source: NHSA and State Council. Licence: CC BY 4.0.
Embed this chart
For automatic sizing and multiple charts, see the JavaScript embed guide.
Free to embed anywhere, including commercially. The attribution bar is part of the chart. The link under the frame is optional: keep it, remove it or mark it rel="nofollow".
Use and publication rights
- View, cite and link: free
Quote any number, cite this page or a single record, and link to it anywhere.
- Copy, chart and republish: free with attribution
The data is published under CC BY 4.0, commercial use included. Credit StatOrigin and the original publisher (NHSA and State Council); the chart files already carry that line.
- The source documents: the publisher's terms
Figures are facts read from the publishers' own documents. The documents themselves, their text and design, stay under each publisher's terms; follow the source links for those.
How this measure is built
- Definition
- Cumulative count of patient visits or individuals benefiting from price-negotiated reimbursement medicines.
- Measure
- One slice of Reimbursement beneficiaries ( basis: cumulative, form: count, segment: negotiated ) . Total number of patients or individuals benefiting from reimbursed pharmaceutical products. Region and period are columns on every record, not slices.
- Limitations
- Values are shown as published; StatOrigin does not revise, fill gaps or convert currencies.
- Verification
- Each value, unit, period and place was checked against its source evidence before publication. See the methodology and the corrections process.
Sources · 2 documents
| Document | Publisher | Published | Data points |
|---|---|---|---|
| 国家医保局 人力资源社会保障部印发2024年版国家医保药品目录 | NHSA | 28 Nov 2024 | 1 |
| 2024年版国家医保药品目录出炉，新增91种药品——让参保人用上更多新药好药_政策解读_中国政府网 | State Council | — | 1 |
Frequently asked questions
What is the latest beneficiaries of negotiated reimbursement drugs?
China: 830 million person-visits in as of 31 Oct 2024.
Where does this data come from?
From 2 documents published by NHSA and State Council. Every figure on this page links to its record, which preserves the original source evidence.
How often is it updated?
Irregularly: the publishers behind this measure do not release it on a fixed schedule. A new figure appears here once it is published and verified.
Can I use this data?
Yes. StatOrigin publishes it under CC BY 4.0: you may copy, chart and republish it, including commercially, with attribution to StatOrigin and to the original publisher.
Cite this page
Cite the page as a data set, or open any record to cite one figure: each record carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Beneficiaries of negotiated reimbursement drugs [Data set]. Retrieved October 28, 2026, from https://statorigin.org/indicators/beneficiaries-of-negotiated-reimbursement-drugs
"Beneficiaries of negotiated reimbursement drugs." StatOrigin, 2026, https://statorigin.org/indicators/beneficiaries-of-negotiated-reimbursement-drugs. Accessed 28 Oct. 2026.
StatOrigin. "Beneficiaries of negotiated reimbursement drugs." Data set, 2026. Accessed October 28, 2026. https://statorigin.org/indicators/beneficiaries-of-negotiated-reimbursement-drugs.
@misc{statorigin_beneficiaries_of_negotiated_reimbursement_drugs_2026, title = {Beneficiaries of negotiated reimbursement drugs}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/indicators/beneficiaries-of-negotiated-reimbursement-drugs}, note = {Data set. Accessed 2026-10-28} }